Penbutolol (Hoe 893d) in primary hypertension. Blood pressure effects, tolerance and plasma concentrations.

Author: AsplundJ, LandahlS, LianderB, OhmanK P

Paper Details 
Original Abstract of the Article :
Penbutolol (Hoe 893d), a long-acting non-selective beta-adrenoceptor blocking agent, was given once daily to 23 patients with primary hypertension, WHO Stages I-II. The dose (50-100mg) needed to achieve the therapeutic goal, i.e. supine diastolic BP less than 95 mm Hg, was titrated individually. On ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1007/BF00542451

データ提供:米国国立医学図書館(NLM)

Penbutolol: A Promising Oasis in the Desert of Hypertension Treatment

Hypertension, a condition characterized by high blood pressure, is a significant public health concern, affecting millions worldwide. This study examines the effectiveness of penbutolol, a beta-blocker, in managing primary hypertension. The authors, like desert explorers seeking a cool respite from the heat, investigated the efficacy of penbutolol in controlling blood pressure. Their research, like an oasis in the desert of hypertension treatment, suggests that penbutolol may be a valuable therapeutic option for patients with primary hypertension.

Penbutolol: A Potential Solution for High Blood Pressure

The study demonstrates that penbutolol was effective in lowering blood pressure in patients with primary hypertension. The authors highlight the safety and tolerability of penbutolol, noting that side effects were generally mild. This research, like a well-worn desert trail, provides a clear path for understanding and managing hypertension with penbutolol.

Managing Hypertension: A Journey Through the Desert of Cardiovascular Health

Hypertension is a serious condition that can increase the risk of heart disease, stroke, and other cardiovascular problems. Understanding the different treatment options available, including beta-blockers like penbutolol, is crucial for managing blood pressure and reducing the risk of complications. This research provides valuable insights into the potential benefits of penbutolol for managing primary hypertension.

Dr.Camel's Conclusion

This study suggests that penbutolol may be a valuable therapeutic option for patients with primary hypertension. Like a skilled desert guide, researchers continue to explore new and effective treatments for hypertension, offering hope for a healthier future.

Date :
  1. Date Completed 1982-09-17
  2. Date Revised 2019-08-13
Further Info :

Pubmed ID

7047173

DOI: Digital Object Identifier

10.1007/BF00542451

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.